The Globe and Mail reports in its Friday, Jan. 31, edition that TD Cowen analyst Aaron Bilkoski has reaffirmed his "buy" recommendation and $5.50 share target for Spartan Delta. The Globe's David Leeder writes in the Eye On Equities column that Mr. Bilkoski resumed coverage on Spartan Delta after coming off research restriction following the close of its recently announced equity financing, which supported accelerated development and value expansion within the Duvernay. Mr. Bilkoski says in a note: "The W.G. Duvernay should be one of the most topical plays in the WCSB in 2025. It has several well capitalized operators active spending nearly $1-billion of capital in aggregate. While it's still relatively early, we believe [Spartan Delta] has demonstrated the quality of this oil/condensate rich-play, and its ability to execute. We estimate the potential value of the Duvernay/share dwarfs [Spartan Delta's] current share price." The Globe reported on Aug. 16 that Desjardins rated Spartan Delta "buy." It was then worth $4.14. The Globe reported on Sept. 27 that National Bank Financial analysts Travis Wood and Dan Payne had reaffirmed their "outperform" recommendation for Spartan Delta. The shares were then going for $3.64.